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ABSTRACT

RNA-SEQ ANALYSIS OF LOCALIZED MST1/STK4
EXPRESSION IN PROSTATE CANCER

Damien Ready
Marquette University, 2016

The SKT4-encoded MST1 is a serine-threonine protein kinase and has known
associations with many diseases and cancer.MST1 plays a critical component of the
Hippo tumor suppressor pathway responsible for limiting cell division and promoting
apoptosis.Loss of MST1 function is associated with poor prognostic outcomes for
cancers, though the mechanism is not well understood.There is increasing evidence that
dysregulation of MST1 can lead to castration-resistant prostate cancer (CRPCa), an
aggressive cancer with limited treatment options.To better understand the mechanistic
underpinnings of CRPCa progression, C4-2 prostate cancer cells were engineered
toexpress MST1 protein directed to a particular subcellular region: membrane, nucleus,
or cytoplasm.Localized MST1 expression resulted in a marked impact to cell growth in
vitroand in vivo, which was further characterized by performing whole transcriptome
profiling using RNA-Sequencing.Multiple genes were identified with altered expression
patterns, which could influence future mechanistic studies of CRPCa progression.
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INTRODUCTION
The Hippo-like MST1 encoded by theSTK4gene is a pro-apoptotic protein kinase
activated by caspase-cleavage.Activated MST1 enters the nucleus and induces chromatin
condensation and eventually DNA fragmentation (Ura, Masuyama, Graves, & Gotoh,
2001).This function plays a role in controlling organ size and tumor suppression by
repressing proliferation and promoting apoptosis.
MST1 is a core signaling component of the Hippo tumor suppressor, also known
as Salvador/Warts/Hippo (SWH), kinase cascade.The Hippo signaling pathway is a
crucial mechanism to limit cell division and promote apoptosis.Most genes in the Hippo
pathway are recognized as tumor suppressors.Loss of MST1 expression has been linked
to cancer promotion with poor prognosis (Kuser-Abali, Alptekin, & Cinar, 2014).
An estimated 27,000 people died of prostate cancer (PCa) in the US in 2015
(National Institutes of Health).Androgen deprivation therapy (ADT) is the first line of
treatment in PCa, but disease progression in spite of the treatment is defined as castrateresistant prostate cancer (CRPCa).Observed metastases or rising serum levels of prostatespecific antigen are the typical method by which patients are classified (Scher, et al.,
2008).Bone metastases are observed in 90% of met with CRPC and have significant
impacts on quality of life with limited treatment options (Hotte & Saad, 2010).
MST1 signaling may have a critical role in the development of CRPC (Cinar, et
al., 2011).Dysfunctional MST1 may allow the metastasis of PCa.In an effort to better
understand the link between CRPCa and MST1 expression, CRPCa model C4-2 cells
were engineered to express MST1 protein in a localized and inducible manner.MST1
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protein was engineered to be localized in the membrane, cytoplasm, or nuclear regions of
the cell.These cells were then harvested and studied by RNA-sequencing technology to
assess the affected change on global gene expression in response to targeted MST1
localization.

OBJECTIVES
The goal of the project was to identify candidate genes which are meaningfully
impacted by changesinMST1 expression in an aggressive prostate cancer cell line.Largescale analyses examining the effect of repressed MST1 have not yet been performed and
represent a gap in our understanding of the full biological impact of this gene on prostate
cancer progression.Down-regulation of MST1 has previously been shown to have poor
prognostic outcomes for patients with cancer (Seidel, et al., 2007; Minoo, et al., 2007;
Ren, et al., 2008).If genes and their compensatory pathways can be identified, it could
represent targets for potential therapeutic action.Next-generation sequencing is the best
technique to generate global, high-quality data capable of analyzing the entire genome in
a relatively unbiased manner.Identifying new therapeutic targets specific to human
cancers starts with better understanding of the biological underpinnings of a disease.

CONTRIBUTIONS
The aim of this project was to identify candidate genes with associations to MST1
expression.Quantitative polymerase chain reaction (qPCR) follow-up and validation of
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these gene symbols could confirm their activity and have implications for treatment in
patients.
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BACKGROUND
GENOME AND THE CENTRAL DOGMA
The genome is the sum total of genetic information carried within an
individual.This information is encoded by deoxyribonucleic acid (DNA) through the
precise ordering of the four nitrogenous bases: cytosine, guanine, adenine, and
thymine.These four chemical units are sufficient for representing all biological life we
have observed.DNA is organized into genes, which are the primary unit of information in
the genome.
Information storage is insufficient to generate useful work, so the gene must be
encoded into an entity, which can execute the needs of the organism.Proteins are chains
of amino acids with diverse chemical properties capable of performing a variety of
molecular functions in the cell.Proteins can be enzymatic (catalyzing chemical reactions)
or structural (providing scaffolding or other support).The amino acid composition of
proteins gives the structures very different chemical properties from DNA and is essential
for life.
While proteins are generally the ultimate product of the information encoded
within a gene, the cell is incapable of directly expressing a protein and must make use of
an intermediary form that can serve as a model for the proteins.Where DNA is intended
for long-term, static storage of genetic information, RNA molecules are produced for
transient use as a blueprint for proteins.This ephemeral nature means that the pool of
RNA molecules in a cell represents a snapshot of a cell at a moment in time.This
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dynamism allows researchers to ascertain cause and effect to stimuli and gain
mechanistic understanding of the underlying biology.
Transcription, the generation of RNA molecules, is not a one-to-one process of
converting DNA into RNA.DNA information, while complete, is often disjointed,
separated by great distances, and intended for mixing disparate sections.The
consequences of such organization mean that a single stretch of DNA can encode many
different form of RNA with potentially wildly different functions.Fully processed RNA is
called messenger RNA (mRNA) and is suitable for translation.This mRNA can be
generated as a combination of DNA elements by a process known as alternative splicing
(Kornblihtt, Schor, Alló, Dujardin, Petrillo, & Muñoz, 2013).These alternative mRNA
isoforms are then translated into proteins with different primary sequence, which can
have varying catalytic or structural activityof related isoforms(Figure 1).Greater than
90% of protein coding genes are alternatively spliced (Pan, Shai, Lee, Frey, & Blencowe,
2008).
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Figure 1 Alternative splicing is the process by which genetic elements can be
combined to generate mRNA and proteins of different functions from the same
source material.DNA
DNA is first transcribed into an unprocessed RNA transcript
containing introns and exons, the introns are removed and the remaining
exonsresult in mRNA isoforms, the mRNAs are then translated into proteins with
different functionality.
The path from DNA
DNA->RNA->Protein
>Protein is considered the Central Dogma of Biology
and represents our understanding of the information transmission of a cell(Crick,
cell
1970).DNA
DNA contains the information, RNA passes the information, and proteins execute
the information.This progression of material was held for many years until viral enzymes
were found which disrupted the pattern.The reverse transcription of RNA to DNA
allowed researchers
esearchers the opportunity to make use of better biochemical techniques to
study DNA.Reverse transcription and amplification of low level transcripts opened a new
paradigm in biological research.
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TRANSCRIPTOME
The pool of all available RNA transcripts in the cell is known as the
transcriptome.Unlike the static genome, the transcriptome can vary in response to
environmental factors, maturation, and carcinogenesis.The transcriptome is a dynamic
entity comprised of transcripts destined to be translated into proteins.The diversity and
abundance of these transcripts is in constant flux and can be diagnostic of cellular
activity.Contrasting the transcriptome of one cellular condition against another can
identify transcripts of differing composition and abundance that may be responsible for a
particular phenotype.

TRANSCRIPTOMICS
MICROARRAY
Analysis of the transcriptome has historically relied on Sanger sequencing
(Sanger & Coulson, 1975).The Sanger chain-termination method generates contiguous
DNA sequence reads for a sample.While a low throughput technique, requiring a purified
sample of no more than a few hundred base pairs, the technique offers a high fidelity
analysis of an organism’s genetic information.
As technology developed, the Sanger method was replaced with DNA
microarrays, whichcan quantitatively measure thousands of DNA fragments
simultaneously to enable global analyses between samples.DNA microarrays contain
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thousands of known probes attached to a surface, the array.These probes are specifically
picked to be representative of genes found within the organism of study.The sample is
exposed to the array and the available transcripts will hybridize to the complementary
probes.Transcripts without a complement will be washed from the plate.Bound
transcripts will generate a fluorescent signal corresponding to transcript abundance and
can be used for quantitation.
While cost effective, DNA microarrays are limited in many ways.They are
dependent upon fully knowing the expected transcript sequences prior to analysis so
informative probes can be generated.The resolution of microarrays is insufficient to
detect single-nucleotide polymorphisms and other low level variants as hybridization
along the rest of the transcript will be sufficient to generate a signal.Non-specific binding
to probe sequences can result in false-positives and attenuate the observed differential
expression result.

RNA-SEQUENCING
Next-generation sequencing technologies applied to analysis of the transcriptome
is referred to as RNA sequencing(RNA-Seq).RNA-Seqoffers many improvements over
alternative analytical methods.RNA-Seqallows for multiplexing of samples, it is
quantitative, and can generate a global profile of an organism in a single
analysis.Compared to the alternatives, RNA-Seq sits in a unique position capable of
analyzing an entire transcriptome without prior understanding of the organism’s
biology.As the technology is relatively young, there are still many technical challenges,
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which must be overcome as best practices are constantly being re-evaluated.Sample
handling, instrumentation, and data processing are all under scrutiny, but the current state
of the art still has much to offer.
In contrast to DNA microarrays, RNA-Seq technology is able to identify
previously unknown sequences.DNA microarrays are limited to the known probe
sequences attached to the plate.The capability to identify novel sequences allows RNASeq to be used on non-model organisms without an established reference genome.Unique
mutations and single nucleotide polymorphisms can also be exposed by RNA-Seq due to
the high fidelity of the technology, which is not susceptible to interference from nonspecific hybridization.
RNA-Seq technology can provide both a qualitative and quantitative view of an
organism’s transcriptome.A qualitative experiment is focused on identifying what
features are present in expressed transcripts – isoforms, which areexpressed in a
particular scenario may not be present in another.A quantitative experiment deals with
quantity of expression changes.The relative differences between transcript abundances
are measured and significant changes are noted.While the two results are similar,
achieving the highest quality data on a qualitative experiment differs from a quantitative
one.Qualitative data attempting to assess novel splice junctions or seeking accuracy in
highly repetitive regions benefits from paired-end data (Au, Jiang, Lin, & Wong,
2010).Quantitative experiments require replicate measurements, with a strong preference
for biological replicates, to inform on the sample variance to identify between group
differences (Love, Huber, & Anders, 2014).Differential expression measurements can
make use of shorter sequences as absolute fidelity is less important than identifying
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unique signature sequences, which can be localized to a specific gene product to assess
abundance.
RNA-Seq technology is capable of producing millions of sequencing reads in a
single experiment.The depth to which a sample can be sequenced typically exceeds the
experimental demands.Determining the appropriate sequencing depth of the experiment
should be decided so as to only collect what is necessary and allow for additional
replicates (Liu, Zhou, & White, 2014).Studies have indicated that there is no significant
experimental improvement when increasing sequencing depth from 10 million to 20
million(Wang, et al., 2011).

RNA PREPARATION
RNA is a relatively delicate molecule and can easily be destroyed during
transcriptome isolation.RNAse enzymes are prevalent and can easily contaminate
laboratory surfaces and buffers(Pelt-Verkuil, Belkum, & Hays, 2008).DNA, a robust
structure, is chemically similar to RNA and is found in large amounts alongside RNA
requiring specific isolation strategies to purify the RNA away from the DNA.
Isolating RNA from a cell lysate is commonlyaccomplished by acidified phenol
extraction (Chomczynski & Sacchi, 1987).A phenol-chloroform mixture is added to equal
volumes of aqueous.The organic and aqueous layers of the solution separate and partition
the cellular components.RNA will be retained in the aqueous layer while proteins, DNA,
and other cellular debris will remain in the organic phase.
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Ribosomal RNA (rRNA) represents >80% of total eukaryotic RNA and should be
eliminated to focus sequencing depth on the coding transcripts(Lodish, Berk, Zipursky,
Matsudaira, Baltimore, & Darnell, 2000).Depletion of rRNAcan be accomplished with
oligonucleotides that hybridize with ribosomal subunit sequences (O'Neil, Glowatz, &
Schlumpberger, 2013).Alternatively, mRNAs can be enriched with oligonucleotides
containing dT ends to hybridize with the poly-A tail of mature RNA, though this can bias
against the large number of transcripts without poly-A tails (Raz, Kapranov, Lipson,
Letovsky, Milos, & Thompson, 2011).
Purified mRNA must be sheared into smaller pieces amenable for
sequencing.Ideal insert size varies between instruments and the fragmentation strategy
must be chosen accordingly.The three primary methods are enzymatic, sonication, or
nebulization.Enzymatic degradation is performed with Ribonuclease III (RNase III) and
creates heterogeneous fragments but can have some biases against non-coding RNAs and
is highly dependent upon accurate DNA quantitation(Wery, Descrimes, Thermes,
Gautheret, & Morillon, 2013).Sonication results in minimal DNA losses, but can have
variable recovery results (Poptsova, et al., 2014).Nebulization is a reproducible method
generating reliable fragment sizes up to 1500bp but requires large DNA inputs (Meyer &
Liu, 2014).

LIBRARY PREPARATION
Preparing isolated RNA for sequencing is a multi-step process to convert the
starting RNA into appropriately sized and labeled DNA molecules (Figure 2).After
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isolating the fragmented RNA, it is reverse transcribed into coding DNA
(cDNA).Reverse transcription requires a primer to initiate the process.Oligo-dT primers
will hybridize with the poly-A tail of mature mRNA and have a strong bias for the 3’ end
of a transcript, at the expense of the 5’ end.Random hexamer primers can be used to
generate more even coverage of a complete transcript at the cost of some homogeneity at
the beginning (Hansen, Brenner, & Dudoit, 2010).The dUTP stranding method was found
to be most effective for second strand marking (Levin, et al., 2010).
The mixed RNA/DNA molecule is purified by exposure to RNase H to degrade
the original RNA template strand.DNA polymerase and DNA ligase are then used to
reconstruct a full cDNA sequence.A sequencing adapter is ligated to each cDNA
molecule before sequencing.The adapter sequence provides an amplification element, a
primary sequencing site, and a barcode to identify the sample.The barcode is a short
identifying sequence, which can categorize a multiplexed sample.Barcode allows a single
instrument run to analyze multiple samples simultaneously.
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Figure 2 Schematic of RNA processing in a typical RNA-seq experiment.1) RNA
molecules are isolated from DNA 2) RNA is fragmented into smaller pieces more
amenable to the available instrumentation 3) First strand synthesis performed to
generate hybird RNA-DNA 4) RNA is degraded and replaced with DNA.
ILLUMINA SEQUENCING
After library preparation the fragments are placed into a flowcell.The flowcell is
lined with primers complementary to the adapter sequences ligated to the fragments.The
fragments hybridize with the primers and remain attached to the flowcell.The attached
DNA is replicated by bridge amplification to create dense clusters of ~1000 homogenous
sequences to enhance signal detection (Morozova & Marra, 2008).
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Figure 3 Schematic of Illumina sequencing.Stationary DNA fragment bound to the
flow cell is exposed to fluorescentlylabeled nucleotides, a nucleotide is ligated to the
complementary strand and fluoresces a distinctive wavelength,, the process
proc is
repeated for the next cycle, potentially identifying a different paired base(EMBLbase
EBI, 2012).
After removal of all reverse strands, the forward str
strands
ands are sequenced
sequenc by
synthesis.Fluorescently-labeled
labeled nucleotides are added to the flow cell and allowed to
hybridize with the forward strand.A terminator prevents more than a single base pair
from ligating to the strand at once.After ligation, a nucleotide emits a distinctive pattern
to uniquely identify the base.Sequencing is performed by repeating these cycles until the
entire complementary strand has been formed (Figure 3).Millions
Millions of clusters can be
sequenced simultaneously.
After recording all of the sequence information for each fragment cluster,
cluster the data
must be processed to remove the adapter sequences and sort the fragments according to
their respective barcodes.The sequencing depth of the instrument is typically more
powerful than is required for an analysis, so multiple samples will be analyzed within the
same flow cell by utilizing a different barcode to differentiate them.
FASTQ
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The FASTQ data format has become the de facto standard for storing and
transmitting next-generation sequencing data.It is a text based format for the sequence
ID, the raw sequence information, and associated Phred quality scores (Figure 4).The
Phred quality score is a logarithmic assessment of base call quality (Table 1).The ASCII
value of each character is assigned an integer value with the higher ASCII value
associated with higher quality.This encoding scheme allows representation of a very large
range of accuracies without excessive storage overhead.

Figure 4 Example FASTQ entries showing three complete reads.Line one provides
instrument specific identification information to uniquely label the read, line two is
the assigned sequence information of the read, line three is a plus-sign optionally
followed by the sequence identification, and line four is the associated Phred quality
score of each individual base call.In this scoring scheme, an ‘h’ is of higher quality
than an ‘e’.

Phred Quality Score
10

Base Call Accuracy
0.9

16
20
30
40

0.99
0.999
0.9999

Table 1 Example Phred quality scores and associated base call accuracy.The Phred
scoring scheme is logarithmic and has implications for longer reads where accuracy
is most important.
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METHODS AND MATERIALS
SAMPLE PREPARATION AND RNA-SEQ
Experimental design, sample preparation, and RNA-Seq acquisition was
performed prior to involvement by Damien Ready.
C4-2 cells, an established model for prostate cancer, were chosen for analysis due
to multiple attractive phenotypes.Unlike healthy prostate, C4-2 cells are androgen
independent, a hallmark of aggressive prostate cancer is insensitivity to androgen and
continued cell growth without exposure to appropriate hormonal regulation.The C4-2
cells also express prostate-specific antigen, which was previously used as a diagnostic
marker of prostate cancer.For these reasons, C4-2 was chosen as an acceptable model
system for analysis.
To study the effects of directed MST1 expression, the C4-2 cells were transfected
with modified MST1.The MST1 was preceded by an inducible transcriptional activation
control, limiting expression of the protein to times when the cell is exposed to the
appropriate antibiotic.Not only was MST1 transcription limited, the protein was directed
to a specific subcellular location by the inclusion of a localization tag.The MST1 would
only be expressed when prompted and located in a specific region of the cell.MST1 was
directed to cytoplasm, membrane, nucleus, or untargeted.Western blotting and
immunofluorescence methods were performed to confirm the subcellular localization of
MST1 protein.Each cell line was prepared in duplicate.
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Cells were lysed 24 hours after treatment with doxycycline to stimulate MST1
expression.Cells were collected in biological duplicate and total RNA was
harvested.RNA quality was assessed before library construction for RNA-Seq.Samples
were analyzed on an Illumina sequencer at the Genomic Core facility of Cedars-Sinai
Medical Center (Los Angeles, CA).Raw reads in the form of FASTQ files were provided
for data analysis of the eight samples (four conditions with two biological replicates).

DATA ANALYSIS
Analysis of the provided FASTQ files and all subsequent analyses werethe goal of
the project and performed by Damien Ready.

FASTQC
FastQC is a quality control tool built for analyzing high throughput sequence data
(Andrews, 2010).It takes a representative sample of the available reads and generates
qualitative and quantitative metrics for assessing the quality of reads from a next
generation sequencing experiment.FastQC was used interactively to note the overrepresentation of the IlluminaTruSeq Adapter sequences and the base quality of many
reads.

CUTADAPT
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Cutadapt is a Python command line tool designed to remove elements from
sequence data (Martin, 2011).After FastQC identified lingeringTruSeq adapter sequences
present on many reads, cutadapt was used to trim low quality base pairs and the
TruSeqadapter sequences from the ends of the reads.Presence of the adapter sequences
interferes with alignment to the reference genome.Although most algorithms have error
tolerance built into the alignment, poor quality sequence data can interfere with the
process.

ALIGNMENT
The IlluminaiGenomes GRCh37 Ensembl for Homo sapiens was used as a
reference genome (Illumina, 2015).Tophat2 was the interface to perform read mapping of
splice junctions found within the data(Kim, Pertea, Trapnell, Pimentel, Kelley, &
Salzberg, 2013).Internally, Tophat2 uses Bowtie2 to perform the alignment of reads to
the reference genome and the remaining unpaired reads are used by Tophat2 to identify
splice junctions between exons(Langmead, Trapnell, Pop, & Salzberg, 2009).

HTSEQ
The HTSeq toolkit contains a variety of utilities for processing next-generation
sequencing data including read-counting, Phred-score analysis, and gene alignment
(Anders, Pyl, & Huber, 2014).The htseq-count tool was used to count the number of
reads assigned to a particular gene.For every read aligned to a gene in the genome, a sum
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of counts was produced, which can be used to get an estimate of transcript
abundance.Notably, the digital count value is susceptible to over-representation from
large genes (more available transcripts to observe) and more sophisticated normalization
is required to contrast transcript abundance than comparison of counts.

DESEQ2

Differential analysis between the samples was performed with DESeq2, which
uses a negative binomial distribution model to approximate read distribution (Love,
Huber, & Anders, 2014).Sophisticated modeling of reads is required for calculating
differential expression to normalize for within sample variance and sequencing depth.As
larger genes are expected to produce more transcripts, normalization for gene size is also
performed.Multiple testing correction was applied through Benjamini-Hochberg
(Benjamini & Hochberg, 1995).

REVIGO

REVIGO is a web service designed to take the results of high-throughput
experiments and test for enriched gene ontologies with minimal redundancy (Supek,
Bošnjak, Škunca, & Šmuc, 2011).The REVIGO service finds meaningful subsets of
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categories by clustering on semantic similarity.REVIGO was run with the medium
similarity using the DAVID p-value for prioritization.

BIODBNET

bioDBnet is a web service which provides mapping information to convert
identifiers from one biological database into another (Mudunuri, Che, Yi, & Stephens,
2009).The bioDBnet service was notably used to convert Refseq mRNA ids into Ensembl
Gene Ids for alignment of the human housekeeping gene set.

DAVID

The DAVID Bioinformatics resource is a web service which identifies enriched
functional and categorical enrichment derived from a list of genes (Huang, Sherman, &
Lempicki, 2009).DAVID service was used to identify enriched biological processes gene
ontologies.

DATA MUNGING
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Manipulation of outputted data was performed with the Pandas data analysis
toolkit(McKinney, 2010).Custom plots were generated with Matplotlib(Hunter, 2007).
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RESULTS
QUALITY
Assessment of the raw read quality with FastQC revealed a startling trend.Quality
of the RNA-Seq data which were originally provided, related to the cytoplasm and vector
replicates was unusable (Figure 5). All reads in the provided FASTQ format provide a
Phred quality score, which is a measure of the probability of the base call being
incorrect.A Phred score of 8 is roughly equivalent to a 45% probability the base call is
incorrect.The box-plot distribution of associated scores in the cytoplasm shows except for
the very first few base pairs of the reads, the majority of the read had a median Phred
score below four.Such scores indicate that the degree of confidence in a single base pair
is essentially random and unusable for alignment to the genome. The cause of the poor
quality is unknown, but the experiment as planned could not proceed.
New cytoplasm and vector samples were generated and sequenced as a separate
analysis.In contrast to the original 75bp reads, the new data was 50bp long.The change in
read length was not expected or desired, but was the resulted delivered by the
resequencing effort.Standalone quality of the resequenced samples was good with no
cause for concern (Figure 6).The median Phred quality score is greater than 32 over the
entire length of the read, indicate >99.9% base call accuracy. In addition to samples being
generated at a different time, they were sequenced with a different methodology.This is
unfortunate and potentially a confounding variable in the analysis as technical differences
between the sequencing lanes and runs could overwhelm any intrinsic biological
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variation.The potential for such a result has been observed previously where technical
limitations have confounded, otherwise notable results(Gilad & Mizrahi-Man, 2015).
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Figure 5FastQC
FastQC quality score along the reads.A) Example high quality data with
Phred
hred quality scores above 30 B) Distribution of Phred
hred quality scores for the
cytoplasm data with unreliable base calls the length of the read.

Figure 6FastQCPhred
hred quality score distribution for resequenced cytoplasm sample.
READ PREPARATION
After initial assessment of read quality, Illumina TruSeq adapter sequences were
detected on many of the recorded reads.
reads.To
To remove this interference which would
negatively impact alignment to the reference genome, the TruSeq adapters and low
quality ends with a Phred quality score <15 were trimmed from all of the
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fragments.Reads which became shorter than 20bp were discarded.All four sample
conditions had roughly equal amount of reads trimmed and discarded for failing to pass
the filters (Table 2).
Sample
Cytoplasm
Cytoplasm
Membrane
Membrane
Nucleus
Nucleus
Vector
Vector

Replicate
1
2
1
2
1
2
1
2

% Trimmed Reads
2.9
4.5
4.3
3.0
2.8
2.7
3.4
2.9

% Discarded Reads
8.2
11.9
13.1
11.0
11.6
11.2
8.8
9.4

Table 2Cutadapt results and the number of filtered reads.The cutadapt processing
trims low quality base pairs and artifical adapter sequences ligated to reads.A
number of reads require trimming and very short reads must be discarded.

ALIGNMENT

Tophat and bowtie alignment to the reference genome saw a high percentage of
aligned reads after the pre-processing (Table 3).The high percentage of alignment
indicates that the pre-processing was successful in removing low quality reads which
would negatively impact alignment.Forcing alignment to ribosomal RNA showed a low
match percentage.
Sample
Cytoplasm
Cytoplasm
Membrane
Membrane
Nucleus
Nucleus
Vector
Vector

Replicate
1
2
1
2
1
2
1
2

% Aligned Reads
96.6
96.1
96.4
96.7
96.5
96.8
95.7
95.5
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Table 3 Percentage of reads aligned by Tophat to the reference genome.Of the
remaining, high-quality reads, a large percentage of them were successfully mapped
to the reference genome.

GENE COUNTING

After reads were aligned to the genome, the transcripts were counted and grouped
according to Ensembl Gene ID.Only reads which could unambiguously be assigned to a
gene were counted (Table 4).Transcripts which are difficult to definitively assign to a
gene were discarded.
Sample
Cytoplasm
Cytoplasm
Membrane
Membrane
Nucleus
Nucleus
Vector
Vector

Replicate
1
2
1
2
1
2
1
2

Unassigned Reads
2,029,757
1,706,095
793,622
1,143,383
1,620,817
1,795,486
1,813,577
1,982,186

Non-Unique Alignment
2,670,239
2,269,278
775,215
1,185,110
1,650,908
1,814,808
2,257,938
2,508,791

Table 4HTSeq count of alignment data discards non-unique features.Reads which
were aligned to multiple locations in the genome or could be assigned to more than
one feature are discarded.

DIFFERENTIAL EXPRESSION

For ease of interpretation, only Ensembl Ids with a protein coding biotype were
considered for differential expression.Differentially expressed genes were those that met
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the filtering criteria of an adjusted pp-value threshold of .01 and an absolute log2 foldchange relative to the vector of at lleast 2.0 (a four-fold
fold difference in expression).

Figure 7 Volcano plot of the cytoplasm sample with respect to vector control.Red
control.
dots represent differentially expressed gene ids while blue does were classified as not
differentially
lly expressed.
Differential expression analysis of cytoplasmic samples observed 142
differentially expressed genes: 94 genes were up
up-regulated
regulated with respect to vector and 48
were down-regulated
regulated with respect to vector (Figure 7).The
.The membrane samples resulted in
3094 differentially expressed genes: 1806 genes were up
up-regulated
regulated with respect to vector
and 1288 were down-regulated
regulated with respect to vector (Figure 8).The
.The nucleus samples
reported 3336 differentially expressed genes: 1965 genes were up
up-regulated
regulated with respect
to vector and 1371 were down
down-regulated with respect to vector (Figure 9)).The membrane
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and nucleus samples were very similar and showed similar patterns over most gene
symbols (Figure 10).

Figure 8 Volcano plot of the membrane sample with respect to vector control.Red
dots represent differentially expressed gene ids while blue does were classified as not
differentially expressed.
Given the large quantity of genes assigned as differentially expressed with respect
to vector in the membrane and nucleus samples, contrast with another dataset was
desired.A previous meta--analysis of RNA-Seq data identified a collection of 3804
housekeeping genes with stable expression patterns in a variety of cell types (Eisenberg
& Levanon, 2013).While
While 98%
% of the housekeeping genes were observed in the membrane
dataset, only 238 of them were differentially expressed.The same trend was observed in
the nucleus, which found 242 housekeeping genes differentially expressed.
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Figure 9 Volcano plot of the nucleus sample with respect to vector control.Red dots
represent differentially expressed gene ids while blue does were classified as not
differentially expressed.
Analysis of the cytoplasm sample was considered more manageable given its
limited subset of differentially expressed gene symbols.The top twenty most overover
expressed and top twenty least-expressed gene symbols are shown with respect to vector
control (Table 5).
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Figure 10 Venn diagram showing the number of overlapping differentially
expressed gene ids in comparison to vector.

Ensembl Gene ID
ENSG00000144339
ENSG00000069206
ENSG00000178573
ENSG00000137872
ENSG00000044524
ENSG00000166292
ENSG00000139209
ENSG00000188580
ENSG00000197977
ENSG00000106541
ENSG00000017427
ENSG00000172572
ENSG00000182601
ENSG00000184672

Gene Name
TMEFF2
ADAM7
MAF
SEMA6D
EPHA3
TMEM100
SLC38A4
NKAIN2
ELOVL2
AGR2
IGF1
PDE3A
HS3ST4
RALYL

Log 2 Fold Change
-4.99
-4.84
-4.42
-4.13
-4.00
-3.90
-3.73
-3.48
-3.41
-3.40
-3.24
-3.23
-3.12
-2.96
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ENSG00000156234
ENSG00000132872
ENSG00000155850
ENSG00000163492
ENSG00000127863
ENSG00000150672
ENSG00000182583
ENSG00000132437
ENSG00000079931
ENSG00000144476
ENSG00000082175
ENSG00000062038
ENSG00000178538
ENSG00000137766
ENSG00000165659
ENSG00000105971
ENSG00000114374
ENSG00000153233
ENSG00000105976
ENSG00000175497
ENSG00000183853
ENSG00000120594
ENSG00000156298
ENSG00000124260
ENSG00000141668
ENSG00000137673

CXCL13
SYT4
SLC26A2
CCDC141
TNFRSF19
DLG2
VCX
DDC
MOXD1
ACKR3
PGR
CDH3
CA8
UNC13C
DACH1
CAV2
USP9Y
PTPRR
MET
DPP10
KIRREL
PLXDC2
TSPAN7
MAGEA10
CBLN2
MMP7

-2.96
-2.92
-2.78
-2.76
-2.70
-2.69
2.78
2.84
2.85
2.87
2.90
2.92
3.00
3.03
3.13
3.15
3.16
3.23
3.42
3.56
3.62
3.94
4.40
4.63
5.02
5.48

Table 5 Cytoplasm’s top forty genes with the most extreme fold change in contrast
to the vector control.A positive number indicates a greater abundance in the
cytoplasm sample while a negative number indicates a lower observed abundance.
Ensembl Gene ID
ENSG00000146477
ENSG00000081051
ENSG00000159674
ENSG00000167751
ENSG00000120903
ENSG00000124664
ENSG00000069206
ENSG00000204175
ENSG00000138207
ENSG00000160862
ENSG00000142515
ENSG00000140563
ENSG00000096088

Gene Name
SLC22A3
AFP
SPON2
KLK2
CHRNA2
SPDEF
ADAM7
GPRIN2
RBP4
AZGP1
KLK3
MCTP2
PGC

Log 2 Fold Change
-9.39
-9.15
-8.14
-7.88
-7.59
-7.53
-7.51
-7.43
-7.40
-7.37
-7.28
-7.24
-7.21
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ENSG00000198300
ENSG00000184012
ENSG00000165092
ENSG00000128165
ENSG00000106541
ENSG00000017427
ENSG00000184672
ENSG00000113580
ENSG00000130224
ENSG00000112837
ENSG00000113196
ENSG00000148516
ENSG00000106829
ENSG00000159217
ENSG00000165659
ENSG00000128710
ENSG00000116962
ENSG00000135333
ENSG00000118922
ENSG00000072041
ENSG00000204389
ENSG00000147231
ENSG00000133124
ENSG00000172716
ENSG00000218336
ENSG00000145147
ENSG00000022267

PEG3
TMPRSS2
ALDH1A1
ADM2
AGR2
IGF1
RALYL
NR3C1
LRCH2
TBX18
HAND1
ZEB1
TLE4
IGF2BP1
DACH1
HOXD10
NID1
EPHA7
KLF12
SLC6A15
HSPA1A
CXorf57
IRS4
SLFN11
TENM3
SLIT2
FHL1

-7.18
-7.16
-7.11
-7.08
-7.05
-6.94
-6.93
8.50
8.51
8.53
8.57
8.68
8.76
9.02
9.10
9.16
9.20
9.21
9.24
9.32
9.36
9.40
9.46
9.75
9.84
10.03
10.19

Table 6 Membrane's top forty genes with the most extreme fold change in contrast
to vector control.Positive number indicates greater abundance in the membrane
sample while a negative number indicates a lower observed abundance.
Differential analysis of the membrane samples showed very large candidate gene
lists in contrast to the vector control.The top twenty most over-expressed and top twenty
least-expressed gene symbols are shown with respect to vector control (Table 6).
The nucleus samples exhibited large candidate gene lists in contrast to the vector
control.The top twenty most over-expressed and top twenty least-expressed gene symbols
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are shown with respect to vector control (Table 7).Analysis showed nearly identical
results to that of the membrane.

Ensembl Gene ID
ENSG00000142515
ENSG00000167751
ENSG00000135373
ENSG00000083307
ENSG00000146477
ENSG00000166342
ENSG00000159166
ENSG00000160862
ENSG00000159674
ENSG00000140563
ENSG00000081051
ENSG00000124664
ENSG00000144481
ENSG00000184012
ENSG00000086205
ENSG00000182795
ENSG00000104413
ENSG00000246705
ENSG00000184363
ENSG00000149418
ENSG00000169554
ENSG00000112837
ENSG00000187772
ENSG00000130224
ENSG00000148516
ENSG00000106829
ENSG00000128710
ENSG00000135333
ENSG00000118922
ENSG00000165659
ENSG00000159217
ENSG00000116962
ENSG00000072041

Gene Name
KLK3
KLK2
EHF
GRHL2
SLC22A3
NETO1
LAD1
AZGP1
SPON2
MCTP2
AFP
SPDEF
TRPM8
TMPRSS2
FOLH1
C1orf116
ESRP1
H2AFJ
PKP3
ST14
ZEB2
TBX18
LIN28B
LRCH2
ZEB1
TLE4
HOXD10
EPHA7
KLF12
DACH1
IGF2BP1
NID1
SLC6A15

Log 2 Fold Change
-13.71
-12.82
-11.74
-10.76
-10.37
-10.34
-10.31
-10.19
-10.03
-10.01
-9.83
-9.58
-9.50
-9.48
-9.39
-9.27
-9.23
-9.22
-9.17
-9.11
8.42
8.47
8.62
8.66
8.69
8.74
8.95
9.03
9.11
9.15
9.27
9.41
9.54

35
ENSG00000133124
ENSG00000147231
ENSG00000145147
ENSG00000204389
ENSG00000218336
ENSG00000172716
ENSG00000022267

IRS4
CXorf57
SLIT2
HSPA1A
TENM3
SLFN11
FHL1

9.54
9.60
9.85
9.86
9.86
10.03
10.13

Table 7 Nucleus' top forty genes with the most extreme fold change in contrast to
vector control.Positive number indicates greater abundance in the nucleus sample
while a negative number indicates a lower observed abundance.

GENE ONTOLOGY

To identify trends in the affected gene lists, the DAVID web tool was used to
identify biological processes thatwere enriched in either the over-expressed or underexpressed groups.The lists were further condensed with the REVIGO tool, which can
provide summary information from larger gene ontology lists by identifying semantically
similar groups.
Cytoplasm samples had over-expressed genes relative to the vector control, which
are enriched in gland development (GO:0048732) biological process.Relative to vector
control, under-expressed genes showed loss of biological processes associated with
regulation of cell shape (GO:0008360).
Genes over-expressed in the membrane relative tothe vector control showed
representation of biological processes associated with skeletal system development
(GO:0001501) and positive regulation of transcription, DNA-templated
(GO:0045893).Genes under-expressed in membrane relative to the vector control showed
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associations with lymphocyte mediated immunity (GO:0002449) and fatty acid metabolic
process (GO:0006631).
Genes over-expressed in nucleus samples relative to the vector control presented
functions associated with neuron differentiation (GO:0030182) and cell adhesion
(GO:0007155).Genes under-expressed in nucleus samples relative to the vector control
showed associations with lymphocyte mediated immunity (GO:0002449) and fatty acid
metabolic process (GO:0006631) – the same as the membrane sample.

HOUSEKEEPING CONTRAST

To assess the probability of the large candidate differential expression lists, the
differentially expressed genes were contrasted against an orthogonal dataset.A previous
study (Eisenberg & Levanon, 2013) examined multiple human tissue analyses from next
generation sequencing technology to identify a subset of the expressed transcripts, which
could be considered to be housekeeping genes that would remain stable given a variety of
cell types and conditions.The authors identified 3804 genes, which showed consistent
expression patterns across the experiments.The genes in the housekeeping dataset had a
large degree of overlap with the observed gene symbols in this study (>95%), but less
than 5% of the housekeeping genes were identified as differentially expressed from this
data.
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DISCUSSION
This study was the first of its kind to attempt a large scale characterization of
localized MST1 expression in C4-2 prostate cancer cells.Several differentially expressed
genes were identified which were affected by MST1 expression, which could have
clinical impact on understanding the mechanism behind CRPC development and
resistance.
While the potential for the different sequencing runs to be a confounding variable
is unfortunate, there has been no evidence to distrust the most profound results observed
between the sequencing runs.The limited number of observed housekeeping genes in the
differential expression lists is encouraging that the results are credible.Analysis with the
sva package (Gilad & Mizrahi-Man, 2015) also failed to definitively identify batch
effects, but given the low sample number, it is difficult to make strong claims.
Of note is the intersection of differentially expressed genes from the three
experimental conditions against the vector control.Of the observed shared genes, fifty of
the genes were consistently over-expressed relative to vector control (Table 8).Notably,
these genes show enrichment for repressing cell proliferation, which would be expected
of increasing a tumor suppressor.Thirty-one of the shared gene symbols across conditions
were under-expressed relative to vector control (Table 9).The under-expressed genes
show enrichment for metabolic processing of proteoglycans, glycoproteins with
glycosaminoglycans, which have some associations with controlling growth (Iozzo &
Schaefer, 2015).
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Ensembl Gene ID
ENSG00000173068
ENSG00000178538
ENSG00000105971
ENSG00000091986
ENSG00000100422
ENSG00000175040
ENSG00000178662
ENSG00000168772
ENSG00000186377
ENSG00000165659
ENSG00000104059
ENSG00000104870
ENSG00000139445
ENSG00000089327
ENSG00000204681
ENSG00000231389
ENSG00000110318
ENSG00000155980
ENSG00000183853
ENSG00000150556
ENSG00000085276
ENSG00000105976
ENSG00000071073
ENSG00000101871
ENSG00000079931
ENSG00000138386
ENSG00000113580
ENSG00000133636
ENSG00000105088
ENSG00000123240
ENSG00000197991
ENSG00000145431
ENSG00000082175
ENSG00000171033
ENSG00000120594
ENSG00000177469

Gene Name
BNC2
CA8
CAV2
CCDC80
CERK
CHST2
CSRNP3
CXXC4
CYP4X1
DACH1
FAM189A1
FCGRT
FOXN4
FXYD5
GABBR1
HLA-DPA1
KIAA1377
KIF5A
KIRREL
LYPD6B
MECOM
MET
MGAT4A
MID1
MOXD1
NAB1
NR3C1
NTS
OLFM2
OPTN
PCDH20
PDGFC
PGR
PKIA
PLXDC2
PTRF

Cytoplasm vs
Vector log2
Fold Change
2.1
3
3.2
2.7
2.5
2.1
2.1
2.3
2
3.1
2
2.3
2.1
2.3
2.1
2
2.3
2.7
3.6
2.4
2.8
3.4
2.1
2.1
2.8
2.1
2.6
2.1
2.4
2.2
2.6
2
2.9
2.5
3.9
2.1

Membrane vs
Vector log2
Fold Change
4.9
6.9
6.3
5.7
5.6
4.6
3.2
5.9
2.7
9.1
2
4.1
2.2
6.7
2.4
5
3.2
6.7
6.8
2.4
5.1
6.1
3.9
7.9
7.1
3.1
8.5
4.7
2.6
2
2.5
6.4
6
5.8
3.7
2.7

Nucleus vs
Vector log2
Fold Change
4.9
7.3
6.5
5.3
5.7
4.9
3.2
5.8
3.1
9.2
2
4.2
2.2
7
2.2
4.8
2.9
6.6
6.8
3.1
5
6.2
3.9
7.8
7.6
3.3
8.3
4.7
2.5
2.1
2.9
6.4
6.1
5.9
3.4
2.9
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ENSG00000134533
ENSG00000117016
ENSG00000180537
ENSG00000203727
ENSG00000205413
ENSG00000136531
ENSG00000082497
ENSG00000115194
ENSG00000154760
ENSG00000101955
ENSG00000113532
ENSG00000144681
ENSG00000125895
ENSG00000156298

RERG
RIMS3
RNF182
SAMD5
SAMD9
SCN2A
SERTAD4
SLC30A3
SLFN13
SRPX
ST8SIA4
STAC
TMEM74B
TSPAN7

2
2.4
2.1
2.6
2.7
2.5
2.5
2.2
2.5
2.2
2.6
2.3
2.5
4.4

4
2.4
3.8
3
3.3
4.7
6.3
5.1
3.2
2.7
2.7
4.6
3.9
5.8

4.3
2.4
3.8
3
3.8
4.6
6.1
5
3
2.8
3.4
4.6
3.7
5.8

Table 8 Intersection of fifty genes, which were over-expressed in comparison to the
vector control in the cytoplasm, membrane, and nucleus samples.
Ensembl Gene ID
ENSG00000123983
ENSG00000042980
ENSG00000069206
ENSG00000106541
ENSG00000198796
ENSG00000163492
ENSG00000165325
ENSG00000120903
ENSG00000242284
ENSG00000156234
ENSG00000150672
ENSG00000120875
ENSG00000197977
ENSG00000044524
ENSG00000096060
ENSG00000182601
ENSG00000017427
ENSG00000172365
ENSG00000161031
ENSG00000144837

Gene Name
ACSL3
ADAM28
ADAM7
AGR2
ALPK2
CCDC141
CCDC67
CHRNA2
CT45A5
CXCL13
DLG2
DUSP4
ELOVL2
EPHA3
FKBP5
HS3ST4
IGF1
OR5B2
PGLYRP2
PLA1A

Cytoplasm vs Membrane vs
Vector log2
Vector log2
Fold Change Fold Change
-2.4
-3.2
-2.5
-4.2
-4.8
-7.5
-3.4
-7.1
-2.2
-3.5
-2.8
-4.3
-2.4
-4.9
-2.4
-7.6
-2
-4.5
-3
-4.3
-2.7
-3.4
-2.6
-3.7
-3.4
-2.3
-4
-5.8
-2.1
-2.5
-3.1
-4.7
-3.2
-6.9
-2.2
-3.9
-2.2
-5.8
-2.2
-5.9

Nucleus vs
Vector log2
Fold Change
-3.1
-3.6
-8.2
-7.1
-3.7
-4.8
-5.5
-8.3
-5.1
-4.4
-3.8
-3.5
-2.1
-5.9
-2.3
-5.3
-8.7
-4.5
-6.8
-6.6
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ENSG00000184672
ENSG00000116574
ENSG00000163993
ENSG00000181433
ENSG00000139209
ENSG00000132872
ENSG00000144339
ENSG00000127863
ENSG00000167723
ENSG00000135226
ENSG00000197415

RALYL
RHOU
S100P
SAGE1
SLC38A4
SYT4
TMEFF2
TNFRSF19
TRPV3
UGT2B28
VEPH1

-3
-2.1
-2
-2.2
-3.7
-2.9
-5
-2.7
-2.4
-2.1
-2.7

-6.9
-2.3
-6
-4.9
-2.7
-6.4
-6.3
-4.6
-3.5
-4.5
-5.4

-7.6
-2.4
-5.5
-5.6
-2.1
-8.5
-6.3
-4.6
-3.7
-5.2
-6.2

Table 9 Intersection of thirty-one genes, which were under-expressed in comparison
to the vector control in the cytoplasm, membrane, and nucleus samples.
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CONCLUSIONS
Future work to study the problem will require confirmation of the candidate genes
represented in these results.Large scale experiments are always subject to false positives
and validation studies are required before proceeding with biological
studies.Confirmation studies with qPCR will be able to validate the results in a highquality quantitative manner.
Additional studies could be performed repeating the analyses in a single
experimental setup to confirm there were no batch effects skewing the results.While there
was no direct indictment of technical effects impacting the final results, questions are
raised as to the magnitude of the observed changes.A follow-up study to remove this
variable would improve confidence in the results.
As with the completion of the Human Genome Project, more questions have been
raised than answered, but this global study has provided a preview of the meaningful
impact of a single gene.Future work could link it or partners to new therapeutic treatment
for those suffering from aggressive prostate cancers.
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CODE

APPENDIX

48
============ Start Makefile ============

SHELL := /bin/bash

.PHONY: symlinksngsqc-noadaptersngsqc-rnaadapters trimgalore tophattophat_filteredtophat-sorted htseq-count genecounts fastqc-pre fastqc-post tophat-origtophat-rrna
OUTDIR=output
BINDIR=bin

TOPHATDIR=$(BINDIR)/tophat-2.0.13.Linux_x86_64
NGSDIR=$(BINDIR)/NGSQCToolkit_v2.3.3

VIRTUALENV_ACTIVATE=$(HOME)/.virtualenvs/mst/bin/activate
$(OUTDIR)/genes_gtf/genes_gtf.csv : src/minimize_gtf.py
# fitler down the complete gtf file to just three
columns: gene_id, gene_name, gene_biotype
# requires pandas
( \

)
symlinks :

source $(VIRTUALENV_ACTIVATE); \
pythonsrc/minimize_gtf.py; \

mkdir -p $(OUTDIR)/datasets
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ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC1_R1.fastq.gz $(OUTDIR)/datasets/orig_nuc_r1.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC2_R1.fastq.gz $(OUTDIR)/datasets/orig_nuc_r2.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC3_R1.fastq.gz $(OUTDIR)/datasets/orig_mem_r1.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC4_R1.fastq.gz $(OUTDIR)/datasets/orig_mem_r2.fastq.gz

ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC5_R1.fastq.gz $(OUTDIR)/datasets/orig_cyto_r1.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_orig/Cinar-BC6_R1.fastq.gz $(OUTDIR)/datasets/orig_cyto_r2.fastq.gz

ln -s $(CURDIR)/data/Bekir_Cinar_reseq/R133-L6-P01CGATGT-Sequences.fastq.gz
$(OUTDIR)/datasets/reseq_cyto_r1.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_reseq/R133-L6-P02TGACCA-Sequences.fastq.gz
$(OUTDIR)/datasets/reseq_cyto_r2.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_reseq/R133-L6-P03ACAGTG-Sequences.fastq.gz
$(OUTDIR)/datasets/reseq_vec_r1.fastq.gz
ln -s $(CURDIR)/data/Bekir_Cinar_reseq/R133-L6-P04GCCAAT-Sequences.fastq.gz
$(OUTDIR)/datasets/reseq_vec_r2.fastq.gz

fastqc-pre :

mkdir -p $(OUTDIR)/fastqc-pre

bin/FastQC/fastqc --threads 4 --outdir
$(OUTDIR)/fastqc-pre $(OUTDIR)/datasets/*.fastq.gz
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ngsqc-noadapters :

python src/ngs_qc_noadapters.py
$(OUTDIR)/datasets/*.fastq.gz

ngsqc-rnaadapters :

# testing difference when there are Illumina adapters
present
python src/ngs_qc_noadapters.py
$(OUTDIR)/datasets/*.fastq.gz
trim-galore :

# this need cutadapt to be on the path, but this is
installed into a virtualenv

# need to execute as a single command the loading of
virtualenv and then running of trim-galore
( \

source $(VIRTUALENV_ACTIVATE); \

python src/trim_galore.py
$(OUTDIR)/datasets/*.fastq.gz; \
)

date
fastqc-post :

mkdir -p $(OUTDIR)/fastqc-post

bin/FastQC/fastqc --threads 6 --outdir
$(OUTDIR)/fastqc-post $(OUTDIR)/trim_galore/*.fq.gz
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tophat-orig :

# perform the alignment from the original output

python src/tophat.py $(OUTDIR)/tophat-orig/
$(OUTDIR)/datasets/*.fastq.gz
date

tophat :

# perform the alignment from the trimmed output USING
GTF WITHOUT RRNA
python src/tophat.py $(OUTDIR)/tophat/
$(OUTDIR)/trim_galore/*.fq.gz
date

tophat-rrna :

# perform the alignment from the trimmed output on
just rrna
python src/tophat_rrna.py $(OUTDIR)/tophat-rrnatranscriptome/ $(OUTDIR)/trim_galore/*.fq.gz
date

tophat-filtered :

# filter the accepted_hits.bam file for reads that map
to more than 3 places
python src/bamtools.py $(OUTDIR)/tophat/
date

tophat-sorted :
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# sort the accepted_hits_filtered.bam file and convert
to .sam for downstream gene counting
python src/samtools.py $(OUTDIR)/tophat/
date

data/Homo_sapiens/Ensembl/GRCh37/Annotation/Genes/genes_no_
rrna.gtf : src/filter_rrna.py
# removerRNA entries from gtf

python src/filter_rrna.py
data/Homo_sapiens/Ensembl/GRCh37/Annotation/Genes/genes.gtf
data/Homo_sapiens/Ensembl/GRCh37/Annotation/Genes/genes_no_
rrna.gtf

htseq-count :

# this needs HTSeq to be on path, but is installed
into virtualenv
#

( \

source $(VIRTUALENV_ACTIVATE); \

python src/htseq_count.py $(OUTDIR)/tophat-rrnatranscriptome/; \
)

date
gene-counts :

# combine all of the gene counts from htseq-count into
isolated tables
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# this needs numpy and pandas inside virtualenv
#

( \

source $(VIRTUALENV_ACTIVATE); \

python src/combine_gene_counts.py
$(OUTDIR)/htseq_count/*.tsv; \
)

date

============ End Makefile ============
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============ Start bamtools.py ============

# Purpose: Run bamtools to filter tophat aligned reads
which align to more than 3 places
importos

importsubprocess
import time
import sys

importconfig
iflen(sys.argv) == 1:

print('Must supply directory')
sys.exit(-1)

root = sys.argv[1]

hits = []

for path, dirs, files in os.walk(root):
forfname in files:

iffname == 'accepted_hits.bam':

filename = os.path.join(path, fname)
hits.append(filename)
forfname in hits:
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print(fname)
filtered_bam = fname.replace('.bam', '_filtered.bam')
commands = []

commands.append(config.BAMTOOLS_BIN)
commands.append('filter')
commands.append('-in')
commands.append(fname)

commands.append('-out')

commands.append(filtered_bam) #outname
commands.append('-script')

commands.append(config.BAMTOOLS_CONFIG)
print(" ".join(commands))
p = subprocess.Popen(commands)

p.wait()

============ End bamtools.py ============
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{
}

============ Start bamtools_options.json ============
"tag" : "NH:<4"

============ End bamtools_options.json ============
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============ Start combine_gene_counts.py ============

#!/usr/bin/env python

# Purpose: Combine gene counts from all tested conditions
importos

importnumpy as np

import pandas as pd
import sys

importconfig
iflen(sys.argv) == 1:

print("Must supply filenames to combine")
sys.exit(-1)
dfs = []

forfname in sys.argv[1:]:
df = pd.read_csv(fname,
sep='\t',

header=None)

df['sample'] = os.path.basename(os.path.splitext(fname)[0])
df.columns = ['identifier', 'counts', 'sample']
dfs.append(df)
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DIR_OUT = os.path.join(config.OUTPUT_DIR, 'gene_counts')
if not os.path.exists(DIR_OUT):
os.makedirs(DIR_OUT)

combined = pd.concat(dfs)
bidx = combined['identifier'].str.startswith('__')
meta_data = combined[bidx].copy()
counts = combined[~bidx].copy()

counts.replace(np.nan, 0, inplace=True)
meta_data.to_csv(os.path.join(DIR_OUT, 'meta_data.csv'),
index=False)
counts.to_csv(os.path.join(DIR_OUT,
'gene_id_counts_long.csv'), index=False)

wide = counts.pivot(index='identifier', columns='sample')
wide.columns = wide.columns.droplevel() # remove the
multiindex

gtf = pd.read_csv(config.MINIMAL_GTF)
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merged = pd.merge(gtf, wide, left_on='gene_id',
right_index=True, how='right')
# move the biotype to a better spot

biotype = merged.pop('gene_biotype')

merged.insert(2, 'gene_biotype', biotype)
merged.to_csv(os.path.join(DIR_OUT,
'gene_id_counts_wide.csv'), index=False)

============ End combine_gene_counts.py ============
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============ Start config.py ============

# Purpose: Central location for holding site specific
configurations.
importos
PROJ_DIR = "mst/"
FASTQ_DIR = os.path.join(PROJ_DIR, "data",
"Bekir_Cinar_orig")

FASTQ_TRIM_DIR = os.path.join(PROJ_DIR, "data",
"Bekir_Cinar_trim")

FASTQ_RESEQ_DIR = os.path.join(PROJ_DIR, "data",
"Bekir_Cinar_reseq")
OUTPUT_DIR = os.path.join(PROJ_DIR, "output")
SRC_DIR = os.path.join(PROJ_DIR, 'src')
BAMTOOLS_CONFIG = os.path.join(SRC_DIR,
'bamtools_options.json')
BIN_DIR = os.path.join(PROJ_DIR, 'bin')

BAMTOOLS_BIN = os.path.join(BIN_DIR, 'bamtools-master',
'bin', 'bamtools')
BOWTIE_DIR = os.path.join(BIN_DIR, "bowtie2-2.2.4")
TOPHAT_DIR = os.path.join(BIN_DIR, "tophat2.0.13.Linux_x86_64")

SAMTOOLS_DIR = os.path.join(BIN_DIR, 'samtools-1.2')
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SAMTOOLS_BIN = os.path.join(SAMTOOLS_DIR, 'bin',
'samtools')

NGS_DIR = os.path.join(BIN_DIR, 'NGSQCToolkit_v2.3.3')
TRIMGALORE_DIR = os.path.join(BIN_DIR,
'trim_galore_v0.3.7')

MINIMAL_GTF = os.path.join(OUTPUT_DIR, 'genes_gtf',
'genes_gtf.csv')
RRNA_GTF = os.path.join(PROJ_DIR, 'data', 'grch37_rrna',
'grch37.rrna.gtf')
CUFFLINKS_DIR =
"/home/MARQNET/1376readyd/mst/bin/cufflinks"

FASTQC_DIR = "/home/MARQNET/1376readyd/mst/bin/FastQC"
IGENOME_GENES = os.path.join(PROJ_DIR, 'data',
'Homo_sapiens', 'Ensembl', 'GRCh37', 'Annotation', 'Genes',
'genes.gtf')
IGENOME_GENES_NORRNA = os.path.join(PROJ_DIR, 'data',
'Homo_sapiens', 'Ensembl', 'GRCh37', 'Annotation', 'Genes',
'genes_no_rrna.gtf')
BOWTIE_INDEX = os.path.join(PROJ_DIR, 'data',
'Homo_sapiens', 'Ensembl', 'GRCh37', 'Sequence',
'Bowtie2Index', 'genome')

BOWTIE_GENOME_FA = os.path.join(PROJ_DIR,
"Homo_sapiens/NCBI/build37.2/Sequence/Bowtie2Index/genome.f
a")
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============ End config.py ============
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============ Start cutadapt.py ============

# Purpose: remove lingering adapter sequences and low
quality bp calls
importos

importsubprocess
importcutadapt
importconfig
filenames = [os.path.join(config.FASTQ_DIR, f) for f in
os.listdir(config.FASTQ_DIR)]
filenames.sort()

out_dir = os.path.join(config.PROJ_DIR, "data",
"Bekir_Cinar_trim")

for f in filenames:

outname = os.path.join(out_dir, os.path.basename(f))
ifos.path.exists(outname):
continue

commands = []
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commands.append("cutadapt")
commands.append("-q")
commands.append("10")
commands.append("-o")

commands.append(outname)
commands.append(f)

print(" ".join(commands))
p = subprocess.Popen(commands, stdout=subprocess.PIPE)
logname = outname + ".log"

stdout, stderr = p.communicate()

with open(logname, "w") as handle:
handle.write(stdout)

============ End cutadapt.py ============
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============ Start deseq2.R ============

library("DESeq2")

outDir<- file.path("..", "output", "deseq2")
plotDir<- file.path("..", "output", "plot")

# Warning if already exists, but need to ensure they are
present
dir.create(outDir)

dir.create(plotDir)
# Convert the two pair vector-experimental dataframe into a
DESeqDataSet
getDESeqDataSet<- function(df, sampleOne, sampleTwo){

# Turn the counts into a matrix, ignore the first (gene)
column
mat<- as.matrix(df[, -1])

rownames(mat) <- df$gene_id

colData<- data.frame(condition=c(sampleOne, sampleOne,
sampleTwo, sampleTwo),
replicate=c(1,2,1,2)

)

colData$condition<- factor(colData$condition,
levels=c(sampleOne, sampleTwo))

# confirm the levels are in order with 'vector' first

colData$condition<- relevel(colData$condition, sampleOne)
ddsPara<- DESeqDataSetFromMatrix(countData=mat,
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colData=colData,

design = ~condition)
ddsPara
}

processDESeqDS<- function(ds, filename,
imageFilename=FALSE){

## Naive way of processing it; seemingly little
difference
#

dds<- DESeq(ds)

maxIterations<- 300

ds<- estimateSizeFactors(ds)

disps<- estimateDispersions(ds, maxit=maxIterations)
dds<- nbinomWaldTest(disps, maxit=maxIterations)
# the normalized counts

deseq_ncounts<- counts(ds, normalized=TRUE)
write.csv(as.data.frame(deseq_ncounts),
file=paste0(sub(".csv", "", filename),
"_normalized_counts.csv"))
res<- results(dds,

pAdjustMethod="fdr")

# sort according to pvalue

res<- res[order(res$padj), ]
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write.csv(as.data.frame(res),
file=filename)

if (imageFilename != FALSE){
png(filename=imageFilename)
plotMA(dds)
dev.off()
}

}

geneCounts<- read.csv(file.path('..', 'output',
'gene_counts', 'gene_id_counts_wide.csv'))
vec_Mem<- geneCounts[, c('gene_id',
'reseq_vec_r2_trimmed',
'orig_mem_r2_trimmed')]

'reseq_vec_r1_trimmed',
'orig_mem_r1_trimmed',

vec_Nuc<- geneCounts[, c('gene_id',
'reseq_vec_r2_trimmed',
'orig_nuc_r2_trimmed')]

'reseq_vec_r1_trimmed',
'orig_nuc_r1_trimmed',

vec_Cyto<- geneCounts[, c('gene_id',
'reseq_vec_r2_trimmed',

'reseq_vec_r1_trimmed',
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'reseq_cyto_r2_trimmed')]

'reseq_cyto_r1_trimmed',

mem_Nuc<- geneCounts[, c('gene_id',
'orig_mem_r2_trimmed',
'orig_nuc_r2_trimmed')]

'orig_mem_r1_trimmed',
'orig_nuc_r1_trimmed',

vecMemDS<- getDESeqDataSet(vec_Mem,

'vector',

'membrane')

processDESeqDS(vecMemDS, file.path(outDir,
'vector_vs_membrane.csv'))
vecNucDS<- getDESeqDataSet(vec_Nuc,

'vector',

'nucleus')

processDESeqDS(vecNucDS, file.path(outDir,
'vector_vs_nucleus.csv'))
vecCytoDS<- getDESeqDataSet(vec_Cyto,
'vector',

'cytoplasm')

processDESeqDS(vecCytoDS, file.path(outDir,
'vector_vs_cytoplasm.csv'))
memNucDS<- getDESeqDataSet(mem_Nuc,
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'membrane',
'nucleus')

processDESeqDS(memNucDS, file.path(outDir,
'membrane_vs_nucleus.csv'))

============ End deseq2.R ============
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============ Start filter_rrna.py ============

# Purpose: Remove rRNA information from a GTF file.
Prevents mapping to ribosome data
import csv

importargparse
import sys

parser = argparse.ArgumentParser(description='filter a GTF
file to remove rRNA')
parser.add_argument('infile', help='input gtf')

parser.add_argument('outfile', help='output gtf')
args = parser.parse_args()
defgen_filtered_rrna(fname):

with open(fname, 'r') as handle:

reader = csv.reader(handle, delimiter='\t')
for line in reader:

if line[1] != 'rRNA':
yield line

defwrite_gtf(fname, lines):

with open(fname, 'w') as handle:

writer = csv.writer(handle, delimiter='\t')
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for line in lines:

writer.writerow(line)
print('Filtering input file: {}'.format(args.infile))
filtered = gen_filtered_rrna(args.infile)

print('Filtered output: {}'.format(args.outfile))
write_gtf(args.outfile, filtered)

============ End filter_rrna.py ============
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============ Start htseq_count.py ============

# Purpose: sum read counts per gene
importos

importsubprocess
import sys

importconfig
iflen(sys.argv) == 1:

print("Must supply root directory containing sorted sam
files")
sys.exit(-1)

DIR_OUT = os.path.join(config.OUTPUT_DIR, 'htseq_count')
if not os.path.exists(DIR_OUT):
os.makedirs(DIR_OUT)

filenames = []

for path, dirs, files in os.walk(sys.argv[1]):
forfname in files:

iffname == 'accepted_hits_filtered_sorted.sam':
filename = os.path.join(path, fname)
filenames.append(filename)
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forfname in filenames:
print(fname)

sample = os.path.basename(os.path.split(fname)[0])
outname = os.path.join(DIR_OUT, sample) + '.tsv'
commands = []

commands.append('htseq-count')

commands.append('-m') #method - author suggests union
commands.append('union')

commands.append('-s') #stranded
commands.append('no')

commands.append('--idattr=gene_id')
commands.append(fname)

commands.append(config.IGENOME_GENES_NORRNA)
print(" ".join(commands))
p = subprocess.Popen(commands, stdout=subprocess.PIPE)

with open(outname, 'w') as handle:
for line in p.stdout:
handle.write(line)
p.wait()

============ End htseq_count.py ============
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============ Start minimize_gtf.py ============

# Purpose: trim unneeded data from GTF
import csv
importos

import pandas as pd
importconfig
fname = config.IGENOME_GENES
defgen_lines(fname):

with open(fname, 'r') as handle:

reader = csv.reader(handle, delimiter='\t')
for line in reader:
yield line

defgen_tokens(lines):
for line in lines:

tokens = line[8].split(';')
row = {}

for t in tokens:

if 'gene_id' in t:

row['gene_id'] = t.strip().replace('gene_id ',
'').replace('"', '')
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elif 'gene_name' in t:

row['gene_name'] = t.strip().replace('gene_name ',
'').replace('"', '')
elif 'gene_biotype' in t:

row['gene_biotype'] = t.strip().replace('gene_biotype ',
'').replace('"', '')
yield row

lines = gen_lines(fname)

tokens = gen_tokens(lines)
df = pd.DataFrame(tokens)

df.drop_duplicates(inplace=True)

df.sort(columns=['gene_name'], inplace=True)
dir_out = os.path.join(config.OUTPUT_DIR, 'genes_gtf')
if not os.path.exists(dir_out):
os.makedirs(dir_out)

df.to_csv(os.path.join(dir_out, 'genes_gtf.csv'),
index=False)

============ End minimize_gtf.py ============

76
============ Start ngs_qc_noadapters.py ============

# Purpose: perform QC on reads without adapters
importos

importsubprocess
import sys

importconfig

args = sys.argv

iflen(args) == 1:

print("Must supply filenames")
sys.exit(-1)

DIR_OUT = os.path.join(config.OUTPUT_DIR, 'ngsqcnoadapter')
if not os.path.exists(DIR_OUT):
os.makedirs(DIR_OUT)

forfname in args[1:]:
print(fname)
command = []

command.append('perl')
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command.append(os.path.join(config.NGS_DIR, 'QC',
'IlluQC_PRLL.pl'))
command.append('-se')
command.append(fname)

command.append('N') # no adapter

command.append('A') # determine fastqencoing
command.append('-c')

command.append('8') # number cpus

command.append('-cutOffQualScore')
command.append('15')

command.append('-statOutFmt')

command.append('2') # delimited output
command.append('-outputFolder')
command.append(DIR_OUT)

command.append('--outputDataCompression')

command.append('g') # gzip compress output
print(" ".join(command))
p = subprocess.Popen(command)

p.wait()

============ End ngs_qc_noadapters.py ============
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============ Start ngs_qc_rnaadapters.py ============

# Purpose: perform QC on reads with adapters
importos

importsubprocess
import sys

importconfig

args = sys.argv

iflen(args) == 1:

print("Must supply filenames")
sys.exit(-1)

DIR_OUT = os.path.join(config.OUTPUT_DIR, 'ngsqcrnaadapters')
if not os.path.exists(DIR_OUT):
os.makedirs(DIR_OUT)

forfname in args[1:]:
print(fname)
command = []

command.append('perl')
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command.append(os.path.join(config.NGS_DIR, 'QC',
'IlluQC_PRLL.pl'))
command.append('-se')

command.append(filename)
command.append('5')

command.append('A') # determine fastq encoding
command.append('-c')

command.append('8') # number cpus

command.append('-cutOffQualScore')
command.append('15')

command.append('-statOutFmt')

command.append('2') # delimited output
command.append('-outputFolder')
command.append(DIR_OUT)

command.append('--outputDataCompression')

command.append('g') # gzip compress output
print(" ".join(command))
p = subprocess.Popen(command)

p.wait()

============ End ngs_qc_rnaadapters.py ============
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============ Start pivot_gene_counts.py ============

#!/usr/bin/env python

# Purpose: pivot gene counts on the combined data to make
for easier filtering
import pandas as pd
gene_ids = "../output/gene_counts_gene_ids.csv"

gene_names = "../output/gene_counts_gene_names.csv"
defpivot_fname(fname):

df = pd.read_csv(fname)

pivoted = df.pivot(index='identifier', columns='source')

pivoted.columns = pivoted.columns.droplevel() # remove the
multiindex
return pivoted

wide = pivot_fname(gene_ids)

wide.to_csv("../output/gene_ids.csv")
wide = pivot_fname(gene_names)

wide.to_csv("../output/gene_names.csv")
============ End pivot_gene_counts.py ============
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============ Start rename_chr_rrna_gtf.py ============

# Purpose: rename the chromosomes in .gtf file to be in
agreement with the Bowtie2 index
importconfig

import pandas as pd
importos

fname = config.IGENOME_GENES
gtf = pd.read_csv(fname, sep='\t')
source = config.RRNA_GTF

rna = pd.read_csv(source, sep='\t')
outname = os.path.dirname(source)
outname += '/renmaed_chr.gtf'

with open(outname, 'w') as writer:
with open(source, 'r') as handle:
for line in handle:

ifline.startswith('chr'):

new = line.replace('chr', '', 1)
writer.write(new)
else:

writer.write(line)
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============ End rename_chr_rrna_gtf.py ============

83
============ Start samtools.py ============

# Purpose: Run samtools to convert and sort the BAM to SAM
output after the tophat mapping
importos

importsubprocess
import time
import sys

importconfig
iflen(sys.argv) == 1:

print('Must supply directory')
sys.exit(-1)

root = sys.argv[1]

hits = []

for path, dirs, files in os.walk(root):
forfname in files:

iffname == 'accepted_hits_filtered.bam':
filename = os.path.join(path, fname)
hits.append(filename)
forfname in hits:
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print(fname)
accepted_bam = fname.replace('.bam', '_sorted.bam')
accepted_sam = fname.replace('.bam', '_sorted.sam')
commands = []

commands.append(config.SAMTOOLS_BIN)
commands.append('sort')

commands.append('-T') # tempfile prefix
commands.append('SORTING')

commands.append('-n') # sort by name
commands.append('-O') # output type
commands.append('bam')
commands.append('-o')

commands.append(accepted_bam) #outname
commands.append(fname)

print(" ".join(commands))
p = subprocess.Popen(commands)

p.wait()

# convert sorted into SAM

commands = []

commands.append(config.SAMTOOLS_BIN)
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commands.append('view')
commands.append('-h')
commands.append('-o')

commands.append(accepted_sam)
commands.append(accepted_bam)
print(" ".join(commands))
p = subprocess.Popen(commands)

p.wait()

============ End samtools.py ============

86
============ Start tophat.py ============

# Purpose: run tophat alignment to map reads to genome
importos

importsubprocess
import time
import sys

importconfig
importargparse

parser = argparse.ArgumentParser(description="align the
fastq reads to gtf")
parser.add_argument("outdir", help="directory to save
output files")

parser.add_argument("filenames", nargs="*", help="fastq
input to process")
args = parser.parse_args()

forfname in args.filenames:
print(fname)
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short_name =
os.path.splitext(os.path.splitext(os.path.basename(fname))[
0])[0]
out_dir = os.path.abspath(os.path.join(args.outdir,
short_name))
if not os.path.exists(out_dir):
os.makedirs(out_dir)

curr_env = os.environ.copy()

curr_env["PATH"] = config.BOWTIE_DIR + ":" +
curr_env["PATH"]
curr_env["PATH"] = config.TOPHAT_DIR + ":" +
curr_env["PATH"]
tophat_command = []

tophat_command.append(os.path.join(config.TOPHAT_DIR,
"tophat"))
tophat_command.append("-p") # number of threads
tophat_command.append("15")

tophat_command.append("--GTF")

tophat_command.append(config.IGENOME_GENES_NORRNA)
tophat_command.append("-o") # output directory
tophat_command.append(out_dir)

tophat_command.append(config.BOWTIE_INDEX)
tophat_command.append(fname)
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print(" ".join(tophat_command))
p = subprocess.Popen(tophat_command, env=curr_env)

p.wait()

============ End tophat.py ============

89
============ Start tophat_rrna.py ============

# Purpose: run tophat to align reads to RRNA to get a sense
of abundance
importos

importsubprocess
import time
import sys

importconfig
importargparse

parser = argparse.ArgumentParser(description="align the
fastq reads to gtf")
parser.add_argument("outdir", help="directory to save
output files")

parser.add_argument("filenames", nargs="*", help="fastq
input to process")
args = parser.parse_args()

forfname in args.filenames:
print(fname)
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short_name =
os.path.splitext(os.path.splitext(os.path.basename(fname))[
0])[0]
out_dir = os.path.abspath(os.path.join(args.outdir,
short_name))
if not os.path.exists(out_dir):
os.makedirs(out_dir)

curr_env = os.environ.copy()

curr_env["PATH"] = config.BOWTIE_DIR + ":" +
curr_env["PATH"]
curr_env["PATH"] = config.TOPHAT_DIR + ":" +
curr_env["PATH"]
tophat_command = []

tophat_command.append(os.path.join(config.TOPHAT_DIR,
"tophat"))
tophat_command.append("-p") # number of threads
tophat_command.append("15")

tophat_command.append("--GTF")

tophat_command.append(config.RRNA_GTF)

tophat_command.append('--transcriptome-only') # align only
to transcriptome
tophat_command.append("-o") # output directory
tophat_command.append(out_dir)
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tophat_command.append(config.BOWTIE_INDEX)
tophat_command.append(fname)

print(" ".join(tophat_command))
p = subprocess.Popen(tophat_command, env=curr_env)

p.wait()

============ End tophat_rrna.py ============
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============ Start trim_galore.py ============

# Purpose: trim reads to remove low quality/adapter
sequences
importos

importsubprocess
import sys

importconfig
args = sys.argv

iflen(args) == 1:

print("Must supply filenames")
sys.exit(-1)

DIR_OUT = os.path.join(config.OUTPUT_DIR, 'trim_galore')
if not os.path.exists(DIR_OUT):
os.makedirs(DIR_OUT)

forfname in args[1:]:
print(fname)
command = []

command.append('perl')

command.append(os.path.join(config.TRIMGALORE_DIR,
'trim_galore'))
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command.append('--output_dir')
command.append(DIR_OUT)

command.append('--gzip')

command.append('--stringency')

command.append('3') # default is one which seems way too
conservative
command.append('--quality')
command.append('15')

command.append('--length')

command.append('20') # discard reads that become shorter
than length
command.append(fname)

print(" ".join(command))
p = subprocess.Popen(command)

p.wait()

============ End trim_galore.py ============

94

